Nutritional Supplementation during Pulmonary Rehabilitation in COPD: A Systematic Review

Abdulelah M Aldhahir, Ahmed M Al Rajah, Yousef S Aldabayan, Salifu Drammeh, Vanitha Subbu, Jaber S Alqahtani, John R Hurst, Swapna Mandal
doi: https://doi.org/10.1101/19000786

ABSTRACT

Background Uptake of nutritional supplementation during pulmonary rehabilitation (PR) for people with chronic obstructive pulmonary disease (COPD) has been limited by an absence of rigorous evidence-based studies supporting use. Our objective were to report and summarise the current evidence supporting use of nutritional supplementation to improve outcomes during pulmonary rehabilitation in stable COPD patients.

Methods A systematic search was conducted up to May 7th, 2019 (registration number CRD42018089142). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used. Six databases were included: Medical Literature Analysis and Retrieval System Online or MEDLARS Online (Medline), Allied and Complementary Medicine Database (AMED), the Cochrane Database of Systematic Reviews, Excerpta Medica dataBASE (Embase), Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Web of Science.

Results This systematic search generated 580 initial matches, of which 24 studies (1035 COPD participants) met the pre-specified criteria and were included. Our analysis does not confirm an impact of nutritional supplementation during PR, but studies, supplements and PR programmes were heterogeneous in nature.

Conclusion There is currently insufficient evidence on the effect of nutritional supplementation on improving outcomes during PR in patients with COPD. Therefore, controversy remains and further research is needed.

INTRODUCTION

Patients with COPD tend to have daily symptoms, reduced exercise capacity, and susceptibility to exacerbations, resulting in reduced health-related quality of life.(1-3) The international GOLD strategy document summarises current approaches to COPD management.(1) Cost-effective treatment approaches for COPD, described in the ‘Value Pyramid’ (4) include: smoking cessation, influenza vaccination, and pulmonary rehabilitation. Multiple high-quality randomised controlled trials and meta-analyses have demonstrated that pulmonary rehabilitation is an effective management strategy in COPD patients, since it improves exercise performance, reduces dyspnoea, reduces the risk of exacerbation, and improves health-related quality of life.(5-10)

Exercise intolerance/limitation is one of the most common problems for COPD patients and this may be compounded by reduced muscle mass and malnutrition. It has been reported that COPD patients may lose body weight and skeletal muscle mass, which leads to muscle weakness and dysfunction impacting functional ability and quality of life.(11) Muscle disuse, caused by a prolonged sedentary lifestyle and voluntary immobilisation, leads to muscle deconditioning and thus, reduced muscle strength and endurance.(12) It has also been postulated that COPD is associated with a myopathy, which may be driven by systemic inflammation.(12) Additionally, being underweight is associated with an increased risk of mortality in COPD.(13) Weight loss predicts mortality and morbidity in chronic lung disease patients.(8) Therefore patients with COPD are at risk of significant morbidity and mortality as a result of changes in body composition and nutritional and metabolic status.

It is been suggested that healthy older adults require additional nutrients compared with young adults to preserve bone and lean mass. For instance, it is recommended that young adult require 0.7 g of protein/ kg body weight per day while the recommendation for older adults is 1.2 to 1.5 g protein/kg body weight/day, especially for people with conditions that require higher levels of protein, such as COPD.(14) Nutritional supplements have been used to overcome malnutrition in patients with COPD. It has been suggested that nutritional support integrated with exercise training may improve exercise activity, decrease the risk of mortality, and improved muscle strength in undernourished COPD patients.(15, 16) A meta-analysis of nutritional supplementation for stable chronic obstructive pulmonary disease by Ferreira et al. in 2012 included 17 randomised clinical trials and concluded that nutritional supplements increased muscle mass and body weight, and improved respiratory function and exercise tolerance in COPD patients who were poorly nourished.(17) Additionally, Collins et al. demonstrated in their meta-analysis of nutritional support and functional capacity in chronic obstructive pulmonary disease that nutritional supplements improved weight and handgrip strength in COPD patients.(18) Both reviews only included randomised clinical trials and it was not necessary for participants to be engaged in PR. We hypothesised that an integrated approach of exercise training and nutritional support might be the best way to seek functional improvements. However, uptake of nutritional supplementation during pulmonary rehabilitation, where the potential benefit may be greatest, has been limited by the absence of rigorous evidence-based studies supporting use. The objective of this systematic review was to report and summarise the current evidence for using nutritional supplementation during pulmonary rehabilitation in stable COPD patients to enhance PR outcomes.

METHODS

Search strategy

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for this systematic review, with Prospero registration number CRD42018089142.(19) The search was conducted up to May 7th, 2019 using Medical Literature Analysis and Retrieval System Online or MEDLARS Online (Medline), Excerpta Medica dataBASE (Embase), Allied and Complementary Medicine Database (AMED), the Cochrane Database of Systematic Reviews, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Web of Science database (table A1, table A2, table A3, table A4, table A5). The search strategy and terms used in this systematic review are described in the Appendix. The bibliography of eligible articles as well as existing systematic reviews in the field were also screened.

Inclusion criteria

The PICOS (P –population, patient, problem; I –intervention; C –control, comparison or comparator; O –outcome) criteria for included studies appear in Table□1. Studies were included in the systematic review if they met all of the following criteria

View this table:
Table 1 PICOS criteria used for inclusion of studies.

  1. Studies of patients with a confirmed diagnosis of COPD.

  2. No evidence of recent exacerbation as described in the individual studies.

  3. Patients enrolled on a Pulmonary Rehabilitation or other exercise training programme.

  4. Patients receiving nutritional supplementation (caloric, non-caloric, powder, liquid, capsule, or tablets) during Pulmonary Rehabilitation or an exercise training program.

Exclusion criteria

We excluded:

  1. Book chapters.

  2. Systematic reviews (but screened the reference lists)

  3. Non-English manuscripts.

  4. Conference abstracts with no full-text.

  5. Non-full text articles.

The main outcomes of interest were to investigate the impact of nutritional supplementation during PR programmes on exercise function, body composition, peripheral muscles strength, respiratory muscle function, and quality of life.

Data collection

Three authors (AA, JH, & SM) screened the titles and abstracts to exclude irrelevant studies. Full texts of the relevant studies were read by the first author (AA) to evaluate if they fulfilled the inclusion criteria. The reference lists of included studies and excluded systematic reviews were also screened; two additional studies were found, and the senior authors (JH & SM) discussed eligibility. Disagreements between authors were resolved by discussion.

Quality assessment

The first and seventh authors (AA & JH) performed risk of bias assessment using the Cochrane Risk of Bias Tool to assess randomised studies, which comprises seven questions, and the Modified Newcastle-Ottawa scale to assess cohort studies, which is also made up of seven questions.(20, 21) For the randomised trials, we scored each of the seven domains as 0 (low risk of bias) or 1 (high risk of bias, or bias unclear). There was therefore a total score between 0 and 7 in which a higher score equates to a higher risk of bias. For cohort studies, each of the 7 domains was scored from 0 (high risk of bias) to 3 (low risk of bias) and we took a mean of the domains to result in a score between 0 and 3 where a higher score represents a lower risk of bias.

Synthesis of results

The main purpose of this systematic review was to report and summarise the current evidence of using nutritional supplementation during pulmonary rehabilitation in stable COPD. A meta-analysis was not attempted due to methodological heterogeneity between studies. Our discussion focuses on the studies at lower risk of bias.

RESULTS

Initially, 580 studies were considered potentially eligible. However, after removing duplicates, 449 titles and abstracts were included. Screening the titles and abstracts resulted in 32 from 449 studies being considered for full-text reading. After reading the full-text of 32 studies, eight further studies were excluded (table A6). Screening the reference list of eligible studies revealed two further relevant studies. Thus 24 studies in total met the inclusion criteria for the systematic review (see Figure 1).

Figure 1.
Figure 1.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Flow Diagram.

The 24 studies comprised five cohort studies and 19 randomised controlled trials (RCTs). The sample size and study duration varied between 8 and 80 participants and six weeks to four months, respectively. A full description of the included RCTs and cohort studies appear in Table 2 and Table 3, respectively. Also, risk of bias assessment for RCT and cohort studies appear in table A7 and table A8, respectively.

View this table:
Table 2. Detailed description of the included RCT studies.
View this table:
Table 3. Detailed description of the included Cohort studies.

Exercise capacity

Data on exercise function, performance, capacity, or endurance were reported in 20 studies using the Endurance Shuttle Walking Test, Incremental Shuttle Walking Test, Six Minute Walk test, Twelve Minute Walk test, treadmill, and incremental or constant work-load cycle ergometry. Seventeen studies found that using nutritional supplements such as high carbohydrates, vitamin D, creatine, or L-carnitine in addition to pulmonary rehabilitation programs had no statistical benefit compared to PR alone.(22, 24-28, 31, 33-35, 37-42, 44) Three studies found that using nutritional supplements (Polyunsaturated fatty acids PUFA and Respifor which is high carbohydrates) had a statistically significant benefit on top of pulmonary rehabilitation.(29, 32, 36)

There was only one study with positive findings at the lowest risk of bias (1/7), in which Sugawara et al. reported increases in Six-Minute Walk Distance (6MWD) by 19.7 ± 24.7 m (less than the minimum clinically important difference). In this RCT the intervention group received a complex supplement twice a day composed of 200 kilocalories, 60% carbohydrates, 15% protein, 25% fat, and 248 μg of omega-3 PUFAs 0.6 with vitamins A, C, and E and a 12 week exercise programme while the control group underwent a 12 week exercise programme only.(29) There were four RCTs with a similarly low risk of bias which demonstrated no benefit of supplementation. Bool et al.(24) reported that using a high carbohydrate supplementation once a day (125 mL of 9.4 g protein, 28.1 g carbohydrate and 4.1 g fat, leucine, n-3 PUFA and vitamin D) over a period of four months within an outpatient pulmonary rehabilitation did not show any significant improvement in exercise performance measured by cycle endurance time (CET) or 6MWT compared to the control PR group who received flavoured non-caloric aqueous solution as a placebo. Similarly, the study by Paulin et al. found that using vitamin B12 for eight weeks during outpatient pulmonary rehabilitation did not show any significant improvement in exercise performance and duration compared to PR alone.(25) Borghi-Silva et al. reported that using L-carnitine twice a day for six weeks did not show significant improvement in exercise performance measured by treadmill and 6MWT when compared to the placebo group, who received saline solution for the same duration.(34) Finally, Faager et al. concluded that using creatine for eight weeks during PR did not improve exercise performance when measured by ESWT compared to the placebo (glucose) group who underwent the same PR.(35)

Body composition

Seventeen trials measured body composition including body weight, fat-free mass, fat-free mass index, and body mass index.

Body weight was one of the most frequent outcomes measured before and after giving nutritional supplementation; 13 studies measured body weight in COPD patients with normal BMI. Eight studies reported that body weight increased significantly following nutritional supplementation compared to the placebo groups (22, 27, 29, 30, 38, 40, 43, 45), and the study by Broekhuizen et al.(42) compared two nutritional supplements regimes which found that both interventions significantly increased body weight. Four studies reported that body weight did not significantly improve in the intervention groups when compared to the placebo groups.(31, 33, 35, 36) Of the RCTs in which body weight significantly increased, there was only one study, that by Sugawara, that had a low risk of bias.(29) This study reported a significant increase in body weight after 12 weeks of 2.6 ± 3 kg in those receiving the complex supplementation (described above) with mean baseline body weight of 50.8 kg, compared to those in the placebo group with mean baseline body weight of 54.8 kg.(29) In the study by Gurgun et al. there were significant improvements in body weight of 1.1 ± 0.9 kg, BMI 0.2 ± 1.4 kg/m2, and in Fat-Free Mass Index (FFMI) (0.6 ±0.5 kg/m2) in those who received 250 ml of 83.3% carbohydrate, 30% fat and 16.7% protein three times a day as an intervention.(27) Of the four studies with negative findings, one study was at low risk of bias.(35) This study found no significant difference in body weight between the creatine intervention group and the placebo group after eight weeks.

Body Mass Index (BMI) was assessed before and after using supplementation in six out of 24 studies.(23, 27, 32, 34, 36, 38) BMI significantly increased in the supplementation group when compared to the placebo group in three studies.(27, 32, 38) Three studies reported no significant difference in BMI between participants who received nutritional supplementation with PR compared to PR only.(23, 34, 36) One RCT at the lowest risk of bias showed no improvement in BMI with carnitine.(34) In contrast, Gurgun et al. reported that BMI significantly increased after receiving nutritional supplement.(27)

Fat-free mass (FFM) was evaluated in nine trials.(29, 30, 33, 36, 37, 40, 42, 43, 45) Three studies demonstrated that FFM increased significantly in comparison with the placebo group but these studies all had some risk of bias.(37, 40, 43) Two (27, 32) out of four studies (27, 32, 36, 42) with some risk of bias reported that FFMI significantly increased in the supplemental group when compared to the placebo group. In contrast, the study by Broekhuizen et al. reported no significant difference in FFMI between the group who received PUFA as an intervention and the placebo group who received palm and sunflower oil with vitamin E capsule as a placebo.(36)

Peripheral muscle strength

Of the 24 studies included in the systematic review, 12 studies measured quadriceps muscles strength, handgrip strength, or both.(22, 24, 26, 28, 29, 31-33, 35-38)

Three studies reported that handgrip strength did not significantly improve in the intervention groups when compared to the placebo groups.(35, 36, 38) Faager et al. being at lowest risk of bias, reported that using carnitine for eight weeks during PR did not significantly improve handgrip strength when compared to the placebo group who received glucose.(35) In contrast, the study by Fuld et al. which had a higher risk of bias, showed significant improvement in the handgrip after using creatine three times a day for two weeks followed by once a day for 10 weeks.(37)

Quadriceps muscle strength was assessed in 12 studies.(22, 24, 26, 28, 29, 31-33, 35-38) Of the 12 RCTs only three studies with 86 participants in total demonstrated positive findings.(29, 32, 37) Sugawara et al. which had a low risk of bias, concluded that quadriceps muscle strength increased significantly after receiving a complex nutritional supplement when compared to the placebo group.(29, 32, 37) However, nine studies reported that using nutritional supplementation during a pulmonary rehabilitation program had no additional effect on quadriceps muscles strength.(22, 24, 26, 28, 31, 33, 35, 36, 38) Bool et al. with a low risk of bias, reported that using a high carbohydrate supplement showed no significant improvement in quadriceps strength when compared to the placebo group.(24) Similarly, the study by Faager et al. showed that using creatine for eight weeks in COPD patients who were enrolled in an eight week PR programme did not reveal significant differences when measuring quadriceps muscles strength compared with those who used placebo.(35)

Respiratory muscle function

Respiratory muscle function was assessed in nine of the 24 included studies (24, 28, 29, 32, 34, 36, 37, 40, 43), of which three were at lowest risk of bias.(24, 29, 34) Sugawara et al. reported that maximum inspiratory pressure significantly improved in the interventional group (39.2 ± 38.9 cmH2O) after receiving the nutritional supplement embedded in 12 weeks of pulmonary rehabilitation compared with the placebo group (0.1 ± 24.1 cmH2O).(29) A small study by Borghi-Silva et al. showed a significant improvement in MIP (40 ± 14 cmH2O) with carnitine compared to placebo (MIP; 14 ± 5 cmH2O).(34) In contrast, in a larger study by Bool et al. did not show a significant improvement in MIP when compared with the placebo group, who received glucose.(24) None of the studies that measured maximal expiratory pressure showed a significant difference between interventional and placebo groups.(32, 36, 40)

Quality of life

Quality of life was assessed in 16 out of 24 studies.(22-24, 26-29, 31-33, 35, 37, 38, 41-43) Eight studies used the St. George Respiratory Questionnaire (SGRQ) (22, 26, 27, 32, 35, 37, 42, 43), six used the Chronic Respiratory Questionnaire (CRQ) (28, 29, 31, 33, 38, 41), three used the Hospital Anxiety and Depression Scale (HADS) (22, 24, 27), and only one study used the COPD Assessment Test (CAT). Overall, only two studies demonstrated a significant improvement in quality of life with supplementation in addition to PR.(29, 37) Sugawara et al. which was at lowest risk of bias, quality of life measured by the Chronic Respiratory Disease Questionnaire significantly improved after receiving a nutritional supplement when compared with placebo group.(29) Fourteen studies showed negative findings including two RCTs, at lowest risk of bias, including the study by Faager et al. using creatine supplementation and the study by Bool et al. using the high carbohydrate supplement, which has been describe above. Faager et al. using creatine for eight weeks during PR did not improve quality of life measured by SGRQ.(35) Similarly, Bool et al. reported that four months of using oral nutritional intervention did not improve quality of life measured by HADS.(24)

DISCUSSION

This review is the first to summarise the potential effects of using nutritional supplementation during pulmonary rehabilitation in patients with COPD. The studies varied in design, and used differing supplements (protein based, vitamin based, amino acid based, carbohydrate based, or fat based), measured various outcomes, and featured different types of pulmonary rehabilitation (home, community, or hospitalised). It is therefore challenging to draw a single conclusion to address whether using a nutritional supplement has additional effects on exercise function, body composition, respiratory muscle function and quality of life during pulmonary rehabilitation. Consequently, appropriately powered studies with suitable designs and sample size to investigate the effect of nutritional support during PR in COPD patients are still needed.

Exercise capacity has been used to quantify the direct effect of nutrition interventions, and to predict mortality and morbidity in COPD patients and other diseases. In this systematic review, the majority of studies demonstrated no improvement in exercise outcomes with nutritional supplementation, compared to PR alone. There were four RCTs with negative findings at low risk of bias (24, 25, 34, 35) which tested carbohydrate, B12, creatine, and carnitine supplementation and just one small RCT with a positive finding which used a complex supplement twice a day composed of 200 kilocalories, 60% carbohydrates, 15% protein, 25% fat, and 248 μg of omega-3 PUFAs 0.6 with vitamins A, C, E.

Body composition is one of the outcome measures that might be expected to improve when using nutritional supplement in COPD patients. Being underweight is associated with an increased risk of mortality in COPD.(13) Low body weight is observed in between 25% and 40% of COPD patients. Among those, 25% have moderate to severe weight loss and 35% have extremely low fat-free mass.(46) In this systematic review, we found that complex nutritional supplementation during PR may increase body weight in population with normal body weight, but we did not find evidence that this occurred with carnitine or creatine. Importantly, improvements in body weight and FFM using nutritional supplementation during pulmonary rehabilitation appear to occur especially in depleted, malnourished, and muscle-wasted patients.(24, 27, 30, 32)

In recent years, researchers have paid attention to the assessment of functional outcomes such as quadriceps muscle strength and handgrip strength. Handgrip strength and quadriceps muscle strength are valid measurements of peripheral muscles strength, and are associated with mortality, morbidity and increased length of hospital stay.(47, 48) In this systematic review, RCTs at low risk of bias did not support the concept that creatine, high carbohydrates, and L-carnitine increase peripheral muscle strength, and we found conflicting evidence for the benefits of complex supplements with one study having positive and another study negative results.

Respiratory muscle weakness in COPD patients may be due to several factors such as acute exacerbations, systemic inflammation, and malnutrition.(49) It has been suggested that nutritional supplements may improve respiratory muscle function. In this systematic review, we found two studies reporting that nutritional supplementation in addition to pulmonary rehabilitation had an extra benefit in improving respiratory muscle function. This was demonstrated by measuring maximum inspiratory and expiratory pressures. The effects were seen only on inspiratory measures, and the authors did not speculate on why they thought this was.

Quality of life may be affected through multiple mechanisms in COPD. The available evidence from this review included one small study demonstrating an improvement in QOL using a complex supplement, and two studies with negative results one of which used creatine and one of which also used a complex supplement.

Strengths and limitations

To our knowledge, this is the only review that reports the effect of nutritional supplementation during pulmonary rehabilitation in stable COPD patients on clinically important outcomes. PR is an evidence-based and cost-effective intervention in COPD and thus maximising outcomes is of great interest to clinicians and patients alike. We have carefully searched the literature and registered our review in advance on PROSPERO. Three independent researchers examined the titles and abstracts for inclusion. Potential limitations are that we only accessed studies in English, and the inherent variation in the included studies, many of which had risk of bias for example with inadequate sample size or absence of a power calculation, variation in outcomes measured, variety in study design, or different pulmonary rehabilitation protocols. It was noticed that there was a variation in the type of supplement either caloric or non-caloric and powder, liquid or tablets. We also observed a variation in the amount, contents and the duration of using supplements.

CONCLUSION

This is the first systematic review to report the value of nutritional supplementation during PR in patients with COPD. It is not possible to draw a definitive conclusion due to the heterogeneity of the supplements, rehabilitation programmes and outcome measures studied. However, nutritional supplements may enhance the benefit of PR programmes, which would be of considerable benefit to those living with COPD. Not all studies showed positive results and there is a real need for further well-designed and rigorous research to address this area. This is particularly true in weight-losing and/or malnourished patients with COPD who are at the highest risk of poor outcomes.

Data Availability

Not applicable

Contributors

AA, JRH, and SM conceived and designed the study. AA performed the initial search and data extraction, while JRH and SM checked the eligibility of the included articles. AA and JRH performed the quality assessment for the included articles. AA wrote the initial manuscript and YD, JQ, SD, AR contributed to the writing of the manuscript. JRH, SM, VS revised the manuscript. All authors read and approved the final manuscript.

Funding

Not required.

Competing interests

JRH, SM, and AA are running a RCT of protein supplementation to enhance PR outcomes in COPD. The product is being supplied by Nutricia. JRH received grants outside the submitted work from pharmaceutical companies that make medicines to treat COPD.

Patient consent

not required

Provenance and peer review

Not commissioned; externally peer reviewed.

Data sharing statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Acknowledgment

We thank Steven Bembridge Medical Librarian at Royal Free London NHS Foundation Trust, UK for his assistance and support in refining the search strategy.

Appendix

View this table:
Table A1. Medline Search Strategy.
View this table:
Table A2. Embase Search Strategy.
View this table:
Table A3. Allied and Complementary Medicine Database Search Strategy.
View this table:
Table A4. CINHAL
View this table:
Table A5. Web of Science
View this table:
Table A6. Excluded Studies
View this table:
Table A7. Risk of bias of the included cohort study
View this table:
Table A8. Risk of bias of the included cohort study

Footnotes

  • ↵* Joint senior authors

Bibliography

  1. 1.↵
    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195(5):557–82.
    OpenUrlCrossRefPubMed
  2. 2.
    Janson C, Marks G, Buist S, Gnatiuc L, Gislason T, McBurnie MA, et al. The impact of COPD on health status: findings from the BOLD study. Eur Resp J. 2013;42(6):1472–83.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Van Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013;68(10):962–3.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Zoumot Z, Jordan S, Hopkinson NS. Emphysema: time to say farewell to therapeutic nihilism. Thorax. 2014;69(11):973–5.
    OpenUrlFREE Full Text
  5. 5.↵
    Wust RCI, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. International Journal of COPD. 2007;2(3):289–300.
    OpenUrl
  6. 6.
    1. Richard ZuWallack LN
    Suzanne C. SC Lareau BF. Patient Information Series: Pulmonary Rehabilitation. In: Richard ZuWallack LN, editor. Am J Respir Crit Care Med American Thoracic Society; 2013. p. 5–6.
  7. 7.
    Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 SUPPL.):4S–42S.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.
    McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015(2):CD003793.
  10. 10.↵
    Evans R, T D-H, S S, Email Evans R, le r, ac, et al. The minimum important difference of the incremental shuttle walk test distance in patients with COPD. Am J Respir Crit Care Med. 2017;195: no pagination.
  11. 11.↵
    Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71(3):733–8.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Resp J. 2005;26(4):703–19.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954–60.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clinical Nutrition. 2014;33(6):929–36.
    OpenUrlCrossRefPubMed
  15. 15.↵
    Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc. 2003;62(4):783–91.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Efthimiou J, Fleming J, Gomes C, Spiro SG. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137(5):1075–82.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD000998.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology. 2013;18(4):616–29.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Physical Therapy. 2009;89(9):873–80.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    OpenUrlFREE Full Text
  21. 21.↵
    Adapted Version of a Modified Newcastle-Ottawa Scale for Single Use in Specific Context. [Available from: http://www.biomedcentral.com/content/supplementary/2046-4053-3-45-S2.pdf.
  22. 22.↵
    van Beers M, Rutten-van Molken M, van de Bool C, Boland M, Kremers SPJ, Franssen FME, et al. Clinical outcome and cost-effectiveness of a 1-year nutritional intervention programme in COPD patients with low muscle mass: The randomized controlled NUTRAIN trial. Clin Nutr. 2019;18:18.
    OpenUrl
  23. 23.↵
    Ogasawara T, Marui S, Miura E, Sugiura M, Matsuyama W, Aoshima Y, et al. Effect of eicosapentaenoic acid on prevention of lean body mass depletion in patients with exacerbation of chronic obstructive pulmonary disease: A prospective randomized controlled trial. Clin Nutr ESPEN. 2018;28:67–73.
    OpenUrl
  24. 24.↵
    van de Bool C, Rutten EPA, van Helvoort A, Franssen FME, Wouters EFM, Schols AMWJ. A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD. Journal of Cachexia, Sarcopenia and Muscle. 2017;8(5):748–58.
    OpenUrl
  25. 25.↵
    Paulin FV, Zagatto AM, Chiappa GR, Muller PT. Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study. Respir Med. 2017;122:23–9.
    OpenUrl
  26. 26.↵
    Ahnfeldt-Mollerup P, Hey H, Johansen C, Kristensen S, Brix Lindskov J, Jensahnfeldt-Mollerupen C. The effect of protein supplementation on quality of life, physical function, and muscle strength in patients with chronic obstructive pulmonary disease. European journal of physical and rehabilitation medicine. 2015;51(4):447–56.
    OpenUrl
  27. 27.↵
    Gurgun A, Deniz S, Argin M, Karapolat H. Effects of nutritional supplementation combined with conventional pulmonary rehabilitation in muscle-wasted chronic obstructive pulmonary disease: a prospective, randomized and controlled study. Respirology. 2013;18(3):495–500.
    OpenUrlPubMed
  28. 28.↵
    Hornikx M, Van Remoortel H, Lehouck A, Mathieu C, Maes K, Gayan-Ramirez G, et al. Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res. 2012;13(1):84-.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Sugawara K, Takahashi H, Kashiwagura T, Yamada K, Yanagida S, Homma M, et al. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respir Med. 2012;106(11):1526–34.
    OpenUrlCrossRefPubMed
  30. 30.↵
    Baldi S, Aquilani R, Pinna GD, Poggi P, de Martini A, Bruschi C. Fat-free mass change after nutritional rehabilitation in weight losing COPD: Role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis. 2010;5(1):29–39.
    OpenUrlPubMed
  31. 31.↵
    Laviolette L, Lands LC, Dauletbaev N, Saey D, Milot J, Provencher S, et al. Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J med food. 2010;13(3):589–98.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    van Wetering CR, Hoogendoorn M, Broekhuizen R, Geraerts-Keeris GJW, De Munck DRAJ, Rutten-van Molken MPMH, et al. Efficacy and Costs of Nutritional Rehabilitation in Muscle-Wasted Patients With Chronic Obstructive Pulmonary Disease in a Community-Based Setting: A Prespecified Subgroup Analysis of the INTERCOM Trial. Journal of the American Medical Directors Association. 2010;11(3):179–87.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Deacon SJ, Vincent EE, Greenhaff PL, Fox J, Steiner MC, Singh SJ, et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(3):233–9.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    Borghi-Silva A, Baldissera V, Sampaio LM, Pires-DiLorenzo VA, Jamami M, Demonte A, et al. L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res. 2006;39(4):465–74.
    OpenUrlCrossRefPubMed
  35. 35.↵
    Faager G, Soderlund K, Skold CM, Rundgren S, Tollback A, Jakobsson P. Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. International journal of chronic obstructive pulmonary disease. 2006;1(4):445–53.
    OpenUrl
  36. 36.↵
    Broekhuizen R, Wouters EF, Creutzberg EC, Weling-Scheepers CA, Schols AM. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax. 2005;60(5):376–82.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean ME, Ward SA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax. 2005;60(7):531–7.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Steiner MC, Barton RL, Singh SJ, Morgan MDL. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax. 2003;58(9):745–51.
    OpenUrlAbstract/FREE Full Text
  39. 39.
    Vermeeren MA, Wouters EF, Nelissen LH, van Lier A, Hofman Z, Schols AM. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2001;73(2):295–301.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1268–74.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    Kubo H, Honda N, Tsuji F, Iwanaga T, Muraki M, Tohda Y. Effects of dietary supplements on the Fischer ratio before and after pulmonary rehabilitation. Asia Pac J Clin Nutr. 2006;15(4):551–5.
    OpenUrlPubMed
  42. 42.↵
    Broekhuizen R, Creutzberg EC, Weling-Scheepers C, Wouters EFM, Schols A. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease. Br J Nutr. 2005;93(6):965–71.
    OpenUrlCrossRefPubMed
  43. 43.↵
    Creutzberg EC, Wouters EFM, Mostert R, Weling-Scheepers C, Schols A. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition. 2003;19(2):120–7.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Menier R, Talmud J, Laplaud D, Bernard M. Branched-chain aminoacids and retraining of patients with chronic obstructive lung disease. Journal of Sports Medicine & Physical Fitness. 2001;41(4):500–4.
    OpenUrl
  45. 45.↵
    Creutzberg EC, Schols A, Weling-Scheepers C, Buurman WA, Wouters EFM. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(3):745–52.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006;100(8):1349–55.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115–20.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respirology. 2013;18(4):616–29.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418–38.
    OpenUrlPubMed
Back to top
Posted June 28, 2019.
Download PDF

Supplementary Material

Data/Code
Email
Nutritional Supplementation during Pulmonary Rehabilitation in COPD: A Systematic Review
Abdulelah M Aldhahir, Ahmed M Al Rajah, Yousef S Aldabayan, Salifu Drammeh, Vanitha Subbu, Jaber S Alqahtani, John R Hurst, Swapna Mandal
medRxiv 19000786; doi: https://doi.org/10.1101/19000786
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area